AI Medical Writing for Study Protocols
ALPHALIFE SCIENCES · Operations & Productivity
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 8 captures on record
What the publisher says
As described on Microsoft Marketplace.
Seamlessly integrated with Microsoft Word 365, AuroraPrime RMA (Regulatory and Medical Authoring) Add-In is a purpose-built extension designed to revolutionize the creation of clinical documentation. Tailored specifically for essential clinical documents like study protocols, this add-in empowers medical writers to produce high-quality outputs with unparalleled efficiency.
Proven Results:
Show the rest of the publisher’s description (20 more lines)
- 90% first draft time reduction
- 45% total writing time reduction
Key Highlights
- Accuracy Automation: GenAI-Powered Study Protocol authoring
- Automatically generates the Study Protocol by integrating upstream data and reference documents.
- Utilizes Generative AI (GenAI) to produce both data-driven and narrative sections.
- Provides organizations with a flexible, no-code approach to customize generated content.
- Built-in quality control ensures high standards of accuracy and compliance.2. Flexible Template Setup: Effortless configuration for various therapeutic areas (TAs)
- Configure templates within two days, with no coding required.
- Easily create templates by extracting structures from existing study protocol samples.
- End-to-End Automation: Seamless workflow integration
- Integrates with document systems to streamline the entire protocol creation process.
- Automatically pre-processes and updates protocol content in response to data changes.
GenAI-Powered Automation Features
- Auto-Population: Automatically incorporates upstream and reference content such as Protocol synopsis and investigational brochure into data-independent sections.
- Summary Generation: Generates content summaries and maintains synchronization with corresponding document sections.
- Quality Assurance: Ensures consistent quality through GenAI-powered writing and built-in validation mechanisms.
For inquiries, please contact us at: sales@alphalifesci.com
About AlphaLife Sciences
AlphaLife Sciences is a global leader in Generative AI-driven clinical development, optimizing medical and regulatory documentation through its AuroraPrime platform. Chosen by 5 of the top 10 global pharma companies and leading CROs, AlphaLife Sciences is backed by prestigious programs such as Johnson & Johnson Innovation JLABS, Microsoft's Pegasus Program, Google for Startups, Nvidia Inception Program, and Veeva's AI Partner Program. The company accelerates drug R&D and regulatory submissions, fast-tracking the delivery of life-saving treatments worldwide.
Preview
2 images
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Compliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Plans and pricing as listed
2 listedSources
Publisher resources
5 linksLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.